- Home
- VRAX vs MBOT Comparison
VRAX vs MBOT Comparison
Compare VRAX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRAX | MBOT |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 145.7M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | VRAX | MBOT |
|---|---|---|
| Price | $0.18 | $2.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.00 | ★ $7.50 |
| AVG Volume (30 Days) | 185.2K | ★ 1.5M |
| Earning Date | 03-10-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | $217,274.83 | N/A |
| Revenue Next Year | N/A | $4,200.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $1.35 |
| 52 Week High | $1.35 | $4.62 |
Technical Indicators
Market Signals| Indicator | VRAX | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 37.26 | 58.13 |
| Support Level | N/A | $2.34 |
| Resistance Level | $0.25 | $2.64 |
| Average True Range (ATR) | 0.02 | 0.15 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 4.63 | 59.66 |
Price Performance
Historical ComparisonAbout VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.